Evidence map›Paper›PMID 25336724›Full record

ArticleThe Journal of infectious diseases2015

Influenza vaccine prevents medically attended influenza-associated acute respiratory illness in adults aged ≥50 years.

Qingxia Chen, Marie R Griffin, Hui Nian, Yuwei Zhu, John V Williams, Kathryn M Edwards, H Keipp Talbot

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Observational
  5. Observational
  6. Article
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Qingxia ChenDepartment of Biostatistics Department of Biomedical Informatics, Vanderbilt University Medical Center.
Marie R GriffinDepartment of Preventive Medicine Department of Medicine Department of Mid-South Geriatric Research Education and Clinical Center Department of Clinical Research Center of Excellence, VA Tennessee Valley Health Care System, Nashville, Tennessee.
Hui NianDepartment of Biostatistics.
Yuwei ZhuDepartment of Biostatistics.
John V WilliamsDepartment of Pediatrics Department of Microbiology and Immunology.
Kathryn M EdwardsDepartment of Pediatrics.
H Keipp TalbotDepartment of Medicine.
Vanderbilt University Medical Center · USVA Tennessee Valley Healthcare System · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Effectiveness of the Influenza Vaccine in the Aging PopulationR01AG043419 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TALBOT, HELEN KEIPP · 2013 to 2015
$954k
EVALUATION OF CONTROL MEASURES AGAINST DISEASES OTHER THAN AIDS-266025462N01AI025462 · NIAID · DIVISION OF PEDIATRIC INFECTIO · PI EDWARDS, KATHRYN MARGARET · 2003 to 2006
–
NCRR NIH HHS 1 UL1 RR024975NCRR NIH HHS UL1 RR024975NIAID NIH HHS N01 AI025462NIAID NIH HHS N01 AI25462NIA NIH HHS 1R01AG043419NIA NIH HHS R01 AG043419PHS HHS 1U181P000184-01
6 · The paper itself

Abstract

backgroundThere are few estimates of effectiveness influenza vaccine in preventing serious outcomes due to influenza in older adults.

methodsAdults aged ≥50 years who sought medical care for acute respiratory illness were enrolled. A nose/throat swab was tested for influenza virus by reverse transcription-polymerase chain reaction. Clinical and demographic data were collected, including verification of receipt of trivalent inactivated influenza vaccination (IIV-3). Adjusted odds ratios were estimated by multivariable logistic regression models with an L1 penalty on all covariates except vaccination status.

resultsA total of 1047 subjects were enrolled from November through April during 5 influenza seasons during 2006-2012, excluding the 2009-2010 season. Of those enrolled, 927 (88%) had complete influenza virus testing, vaccination status, and demographic data obtained. Of 86 (9.3%) influenza virus-positive patients, 47 (55%) were vaccinated. Of 841 influenza virus-negative patients, 646 (76.8%) were vaccinated. Over 5 influenza seasons, IIV-3 was 58.4% effective (95% confidence interval [CI], 37.0%-75.6%) for the prevention of medically attended laboratory-confirmed influenza illness in adults aged ≥50 years and 58.4% effective (95% CI, 7.9%-81.1%) in adults aged ≥65 years.

conclusionsInfluenza vaccine was moderately effective in preventing influenza-associated medical care visits in older adults.

Indexed as

VaccinationAgedCase-Control StudiesFemaleHospitalizationHumansInfluenza, HumanInfluenza VaccinesLogistic ModelsMaleMiddle AgedMultivariate AnalysisNoseOrthomyxoviridaePharynxProspective StudiesInfluenza VaccinesVaccines, Inactivatedcontrol-negativeelderlyinfluenza vaccine effectivenessolder adults

Identifiers

PMID25336724
PMCPMC4432432
OpenAlexW2104887792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.